ADCMC launches ‘Abu Dhabi Standard for Healthcare Business Continuity' to enhance emergency medical service operations
The initiative is a key progress of Abu Dhabi's ongoing efforts to position itself as a global leader in the implementation of business continuity practices. It lays down a comprehensive and detailed framework aimed at strengthening the business continuity management system for healthcare services across the Emirate. The benchmark will also help Supporting healthcare sector resilience by minimising the impact of disruptions, and safeguarding patient safety while facilitating seamless and uninterrupted service delivery. Furthermore, it ensures the availability of essential healthcare services at all times, as well as full compliance with regulatory and legislative requirements.
The standard is tailored to ensure the continuity of healthcare and emergency medical service operations across the Emirate of Abu Dhabi, fostering an integrated, patient-centric care system. It primarily focuses on driving timely and uninterrupted response to critical emergencies through the seamless coordination of resources and expertise. In addition, it aims to minimise service disruptions stemming from emergencies, crises, and disasters. This is essential to enhance the safety and well-being of patients, visitors, and healthcare professionals, while strengthening service continuity across the Emirate, right from pre-hospital services to diagnostics, and treatment.
His Excellency Matar Saeed Al Nuaimi, Director General of ADCMC, reaffirmed the Centre's unwavering commitment to advancing the emergency, crisis, and disaster management system, as well as elevating the resilience and sustainability of the Emirate's healthcare sector. His Excellency emphasised the need to establish comprehensive, integrated standards that ensure both essential service continuity and patient safety under all circumstances. H.E. Al Nuaimi also stated that the initiative aligns with the Centre's strategic vision to enhance Abu Dhabi's preparedness for emergencies and crises, further solidifying its position as a global leader in this critical domain.
His Excellency further stated: 'The health and well-being of the population remain a top priority for the Emirate of Abu Dhabi, aligning with the government's aim to provide an exceptional quality of life for all residents and ensure the continuity of essential healthcare services. Achieving this exemplary vision necessitates strict compliance with the regulatory and legislative frameworks, as well as the effective implementation of key requirements by all stakeholders within the healthcare sector. In such a scenario, it is also essential to proactively identify and manage strategic risks at the Emirate level, by understanding their potential impact on healthcare, reinforcing both social and economic stability.'
His Excellency also eemphasised the newly introduced standard's critical role in enhancing the healthcare sector's capacity, and establishing a flexible business continuity management system to ensure the sustainability of healthcare services, even during emergencies. H.E. Al Nuaimi remarked that such a system empowers healthcare providers to effectively adapt to evolving challenges and respond swiftly to a wide range of crisis situations.
H.E.Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH said: 'Abu Dhabi has made remarkable strides in strengthening the readiness of its healthcare ecosystem, ensuring the sustainability and continuity of its services in times of crisis. Collaboration, joint efforts, and integration between all stakeholders have played a vital role in achieving the Emirate's milestones in that regard. Today, Abu Dhabi proudly ranks among the world's most innovative and resilient healthcare systems in emergency preparedness and response. This achievement is no coincidence, but a direct result of our wise leadership's steadfast support and guidance in prioritising the community's health and safety above all. Through coordinated efforts to drive innovation, harness the latest technologies, and continuously advance infrastructure and regulatory frameworks, Abu Dhabi continues to set a distinguished global example.'
H.E. added: 'We are proud of the collaboration between the Department of Health – Abu Dhabi, the Abu Dhabi Public Health Centre, and the Abu Dhabi Emergency, Crisis and Disaster Management Centre in launching the Abu Dhabi Business Continuity Standard for Heathcare. This initiative is designed to further strengthen the readiness of healthcare facilities across the Emirate, ensuring the uninterrupted delivery of care services, enhancing integration among key stakeholders, unifying response frameworks, and bolstering operational resilience to enable faster recovery from crisis, all without compromising the quality of healthcare services.'
The Abu Dhabi Standard for Business Continuity in Healthcare Activities applies to all healthcare providers, based on the applicability of requirements to their specific operational environments and service providers. It also encompasses additional requirements for pre-hospital and critical care, as well as hospitals in general. The focus is primarily on the time taken to deliver relevant healthcare services, and the hospital's ability to respond to emergencies, crises, and disasters that may disrupt social systems.
It also addresses critical incidents and emerging risks impacting the health of community members. In such instances, coordinated efforts are required to ensure that healthcare providers can respond effectively and mitigate adverse health outcomes in their facilities and across communities.
Furthermore, the capability of the healthcare sector is determined by several factors such as the development of hospitals that empower healthcare professionals to deliver medical care focused on emergency and critical care, efficiently manage emergency calls and coordinate ambulance deployment. It is also dependent on the efficiency of emergency patient transportation service providers, multidisciplinary response teams that provide clinical interventions at the incident site, as well as medical hotlines that offer remote diagnosis and instructions to facilitate certain treatments.
Non-emergency patient transport services for hospital transfers and discharges, along with a range of other resources, including personnel, skills, equipment, technology, materials, and information, also play a critical role in emergency and crisis situations. This also includes effective governance, which lays down the acceptable boundaries for healthcare conduct and practices.
The Department of Health – Abu Dhabi recently inaugurated the Unified Medical Operations Command Centre (UMOC), the first of its kind globally. Operated by the Abu Dhabi Public Health Centre, in collaboration with a number of public and private sector healthcare entities, the Centre is designed to strengthen cooperation and coordination among all stakeholders. It serves as a central hub for emergency management, marking a major addition to the Emirate's healthcare sector and playing a vital role in safeguarding public health, enhancing emergency preparedness, and strengthening response capabilities
ADCMC remains steadfast in its efforts to reinforce the Emirate's adaptability and preparedness to tackle future challenges through a range of forward-looking studies, research, and plans aimed at enhancing crisis response capabilities. These include joint drills and exercises with various public and private sector entities, as well as collaboration with partners to promote cooperation and knowledge exchange in the field of emergency and disaster management. ADCMC is also committed to developing infrastructure to ensure rapid and effective response to emergencies, crises, and disasters.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
18 hours ago
- Al Etihad
Abu Dhabi to partner with GEMMABio Therapeutics, advance gene therapies for children with spinal muscular atrophy
5 July 2025 19:52 ABU DHABI (WAM)The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has announced its plans to partner with GEMMABio Therapeutics (GEMMABio), a pioneering global biotechnology company dedicated to advancing global access to gene therapies for rare diseases, in collaboration with M42, a global health champion powered by AI, technology and genomics, and PureHealth, the largest healthcare group in the Middle East. The announcement follows a high-level meeting, during the BIO International Convention 2025 in Boston, between senior leaders from GEMMABio and key stakeholders from Abu Dhabi's health and life sciences ecosystem. Through this strategic partnership, the entities will jointly establish dedicated manufacturing and research centres within Abu Dhabi's academic health institutions, enabling patients from across the MENA region to access cutting-edge clinical trials and, eventually, approved gene collaboration will kick off with a clinical trial evaluating a next-generation gene therapy product in children with spinal muscular atrophy type 1 (SMA1), setting a precedent for expanding access to life-saving therapies Mohamed Alameri, Acting Director of Genome and Biobank Division at the Department of Health – Abu Dhabi, said, 'Our partnership with GEMMABio marks a pivotal step in Abu Dhabi's journey to become a global leader in developing gene therapies for rare diseases leveraging the Emirati Genome Programme. At DoH, we are committed to reshaping innovation, early detection and personalised care by strengthening the Emirate's capacity to develop, test and scale innovative therapeutics. Through these efforts, we are advancing life sciences applications while offering real hope to patients and families across the region and beyond.'The collaboration will unite the shared vision and technology to further strengthen Abu Dhabi's gene therapy R&D ecosystem, and see the emirate serving as a regional hub for GEMMABio's translational and clinical research activities.A best-in-class gene therapy contract development and research manufacturing organisation will be established in Abu Dhabi as a joint venture between M42 and GEMMABio. Additionally, regional access to GEMMABio's commercialised gene products will be coordinated through Abu Dhabi's gene therapy research and treatment by the emirate's state-of-the-art infrastructure, forward-looking policies and the Health, Endurance, Longevity and Medicine (HELM) Life Sciences Cluster, Abu Dhabi is offering streamlined licensing and co-commercialisation processes, alongside co-investment schemes and tax relief for biotech startups. Together, these enablers position Abu Dhabi as a leading global hub for life sciences Jim Wilson, Founder, President, and CEO of GEMMABio, said, 'This is a transformational partnership—one that will play a pivotal role in unlocking global access to life-saving treatments for patients with rare diseases. The stakeholders in Abu Dhabi are building a globally recognised gene therapy ecosystem whose impact on the future of life sciences will be both profound and far-reaching. Together, we are aligning scientific innovation with bold ambition to accelerate progress where it's needed most.'Dimitris Moulavasilis, Group Chief Executive Officer of M42, said, 'This partnership helps Abu Dhabi usher in another frontier in the future of health. With our integrated AI- and data-led ecosystem and advancements in precision, prevention, and prediction, this collaboration extends the impact of the Emirati Genome Programme into gene therapeutics targeting rare diseases."M42 is focused on developing genomic insights, fighting against rare diseases and saving lives. Our partnership with the Department of Health – Abu Dhabi and GEMMABio will accelerate this effort, ensuring people in the UAE and beyond get the gene therapies they need for longer, healthier lives.'This strategic partnership reinforces Abu Dhabi's recent strides in rare disease gene therapies and precision medicine. The emirate has significantly expanded its genomics capabilities through the Emirati Genome Programme, with over 800,000 genome samples sequenced, marking one of the world's most advanced national genomic Dhabi continues to pioneer the administration of cutting-edge gene therapies, expanding access to life-saving treatments that were previously unavailable in the region. With sustained investment in research, talent, and infrastructure, the emirate is reinforcing its position as a regional leader in life sciences and medical Saif Al Qubaisi, Group Chief Operating Officer of PureHealth, said, 'This collaboration is a powerful reflection of Abu Dhabi's growing influence as a global centre for health innovation. By joining forces with GEMMABio and our strategic partners, we are not only expanding access to advanced gene therapies, but also reinforcing the Emirate's long-term commitment to solving some of the world's most complex health challenges. PureHealth is proud to contribute through its integrated research capabilities and commitment to clinical excellence, aligned with the Department of Health's vision to deliver life-changing outcomes for patients across the region and beyond.'Led by DoH, a high-level delegation embarked on a strategic mission to the US from June 15 to 21, 2025. This visit focused on knowledge exchange, investment opportunities, and the signing of new agreements aimed at accelerating the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation included key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), and startAD.
Gulf Today
a day ago
- Gulf Today
DoH advances paediatric cell and gene therapy
The Department of Health - Abu Dhabi (DoH) has signed a strategic Memorandum of Understanding with Children's National Hospital in Washington, D.C., to establish the Abu Dhabi - Children's National Hospital Cell and Gene Therapy Clinical Excellence Programme. The partnership marks a major step in advancing access to paediatric cell and gene therapies across the UAE. The agreement outlines joint fellowships, training programmes and workshops aimed at developing local expertise, positioning Abu Dhabi as a global hub for innovation in life sciences. Dr Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at DoH, said the partnership reflects Abu Dhabi's integrated, patient-centred approach to healthcare. She added, "By combining global expertise with local ambition, we are building a care model that is sustainable, scalable and tailored to the needs of our youngest patients." Michelle Riley-Brown, President and CEO of Children's National, said the collaboration builds on a long-standing partnership with the UAE, aiming to fast-track the development of cutting-edge therapies and offer new hope to children and families. The initiative will drive development and delivery of advanced therapies such as Virus-Specific T-cell therapies (VST), with plans to establish Good Manufacturing Practices (GMP) compliant facilities, standardise treatment protocols, and streamline clinical trial systems in Abu Dhabi. The agreement also covers joint biobanking, data governance improvements and long-term patient care integration. A major component includes Emirati clinician-scientist fellowships and the co-development of specialised training in cellular immunotherapy and trial management. The partnership will introduce virtual tumour board sessions and hands-on training in cell therapy manufacturing, quality control, and clinical procedures. Complementary workshops will focus on Investigator-Initiated Trials (IITs) and regulatory design, strengthening Abu Dhabi's healthcare workforce. The agreement follows a high-level Abu Dhabi delegation visit to the United States from 15th to 21st June, 2025, focused on health innovation and investment. Participants included the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, Etihad Cargo, NYU Abu Dhabi, Khalifa University, MBZUAI and startAD. WAM
The National
2 days ago
- The National
Struggling to concentrate? Experts' tips for reclaiming focus
Most people won't make it to the end of this article. If you've come even this far, you're clearly intrigued by the subject matter, but the estimated reading time of nearly four minutes is five times longer than the average attention span today. Every single day, most of us glance at our smartwatch while talking to someone, pick up our phone as we watch a TV show, or scroll through social media when we have a couple of minutes to spare. Not only is technology distracting many from the real world, but even when they're logged in, they dedicate just a few seconds to each new nugget of information before succumbing to the draw of another tab. All of this points to not only an alarming overuse of gadgets, but also the equally troubling inability to focus. Why our attention spans have waned 'There is no doubt that technology has profoundly affected our ability to focus in the short term,' says Rami Shtieh, a mental health practitioner at BodyTree Studio, Abu Dhabi. 'Our collective humanity is subject to a constant blitz of notifications from smartphones, emails and social media alerts, which results in fragmented attention that makes sustained focus increasingly difficult.' With so much at our fingertips in an instant, our brains are being conditioned to expect constant stimulation, moving away from a sustained attention span. In her book Attention Span: A Groundbreaking Way to Restore Balance, Happiness, and Productivity, psychologist and attention expert Dr Gloria Mark notes that in 2004, the average attention span on any screen was two and a half minutes, decreasing to 75 seconds in 2012 and just 47 seconds in recent years. 'This reduction is largely driven by the way digital platforms are designed – to be stimulating, rapid and rewarding,' says Dr Lara Foresi, psychiatrist at Thrive Wellbeing Centre, Dubai. 'Social media, for example, encourages fast scrolling, short video formats and notifications that constantly pull our attention away. These platforms capitalise on intermittent reinforcement, which makes users repeatedly check for updates, likes or new content. 'As a result, our brains are increasingly wired to crave novelty and rapid information delivery, making it harder to engage in slower, more reflective cognitive processes such as reading a book, having a deep, uninterrupted conversation or even watching a full-length film.' The impact of this goes beyond the superficial, such as skipping songs or accidentally doom-scrolling – it can also be detrimental to our wellbeing. How lost focus can affect wellbeing 'Cognitive overload and constant distractions can lead to chronic stress,' says Dr Muhamed Hamza, clinical psychologist at Lighthouse Arabia, Dubai. 'As people struggle to maintain focus, feelings of incompetence and frustration can arise, exacerbating mental health issues. Evidence indicates that prolonged difficulties with focus can lead to struggles such as chronic anxiety and depressive symptoms.' Devika Mankani, psychologist at The Hundred Wellness Centre, Dubai, adds: 'When our attention is fragmented, we lose more than productivity. We lose presence. Emotionally, it can erode the richness of our relationships as a distracted mind rarely finds rest.' Another long-term effect, say experts, is on our sense of self. 'As the ability to be fully present erodes, so too does our capacity to connect inwardly with ourselves,' says Dr Enrica Verrengia, specialist psychiatrist at BPS Clinic, Dubai. 'People living in states of chronic distraction frequently report a sense of disconnection from meaning, from purpose and from the values that once grounded them. This isn't merely a psychological effect; it reflects a deeper breakdown in the continuity of inner life. Studies have shown that excessive media multitasking is associated with a fading sense of identity, a loss of clarity about the self and a growing feeling of existential emptiness.' Tips and tactics for reclaiming focus To take action, it's essential to recognise what constitutes a chronic lack of focus. Natural distractibility is a part of being human, and a person's focus will shift throughout the day depending on various factors, such as the sleep duration and quality, hunger, interest in a task and external diversions. However, when lowered focus begins to affect not only your work and relationships, but also your overall happiness, it's time to take action. Eliminating technology isn't realistic, so adding steps to your daily routine may help instead. A daily mindfulness practice is a good place to start. 'Research consistently shows that mindfulness practices, such as meditation, can significantly improve focus and attention,' says Hamza. 'Even short periods of mindfulness training can enhance sustained attention and cognitive control. Incorporating daily mindfulness can help retrain the brain to stay focused for longer periods.' Recognising situations and times when inattention is likely to occur is key to removing the temptation of what might distract you from work, family or personal time. Time-blocking, or carving out specific parts of the day to focus on particular tasks, can help create a more organised approach, along with swapping multitasking for monotasking and focusing on one thing at a time. 'Implement structured work periods,' says Shtieh. 'Use tactics such as the Pomodoro Technique, where you work for 25 minutes followed by a five-minute break. This approach has been shown to boost productivity by providing regular opportunities to recharge.' Additionally, the Deep Work technique, introduced by Cal Newport in his book of the same name, advocates setting aside distraction-free blocks of time, usually 60 to 90 minutes, dedicated to cognitively demanding tasks. 'Planning these sessions daily and treating them as non-negotiable helps reinforce their value,' says Foresi. 'Ending each session with a clear goal or stopping point ensures progress and maintains motivation.' When it comes to technology, turning off notifications and setting screentime limits can help you regain control. Additionally, physical activity has been shown to improve cognitive function and attention in both the short and long term. Mankani says: 'We don't need to abandon technology, but we do need to renegotiate our relationship with it consciously, compassionately and consistently. Focus is not lost – it's simply waiting to be reclaimed.'
